AptarGroup, Inc. (ATR)
| Market Cap | 9.26B |
| Revenue (ttm) | 3.49B |
| Net Income (ttm) | 284.49M |
| Shares Out | 66.17M |
| EPS (ttm) | 4.25 |
| PE Ratio | 32.94 |
| Forward PE | 26.58 |
| Dividend | $1.64 (1.17%) |
| Ex-Dividend Date | Apr 24, 2024 |
| Volume | 423,771 |
| Open | 139.95 |
| Previous Close | 139.74 |
| Day's Range | 139.50 - 140.90 |
| 52-Week Range | 111.63 - 145.35 |
| Beta | 0.58 |
| Analysts | Strong Buy |
| Price Target | 149.00 (+6.42%) |
| Earnings Date | Apr 25, 2024 |
About ATR
AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; an... [Read more]
Financial Performance
In 2023, AptarGroup's revenue was $3.49 billion, an increase of 4.97% compared to the previous year's $3.32 billion. Earnings were $284.49 million, an increase of 18.89%.
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for ATR stock is "Strong Buy." The 12-month stock price forecast is $149.0, which is an increase of 6.42% from the latest price.
News
Aptar Declares Quarterly Dividend
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Declares Quarterly Dividend.
Aptar Reports Fourth Quarter and Annual 2023 Results
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Reports Fourth Quarter and Annual 2023 Results.
Aptar Declares Quarterly Dividend and Announces 2024 Annual Meeting Details
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Declares Quarterly Dividend and Announces 2024 Annual Meeting Details.
Aptar Announces 2024 Quarterly Conference Call Dates
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar announces 2024 quarterly conference call dates.
Aptar Reports Third Quarter 2023 Results
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Reports Third Quarter 2023 Results.
Aptar Named Among the 100 Best Corporate Citizens for Third Consecutive Year
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Named Among the 100 Best Corporate Citizens for Third Consecutive Year.
Aptar Appoints Global Finance and Operations Veteran Sarah Glickman to its Board of Directors
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar appoints global finance and operations veteran, Sarah Glickman, to its Board of Directors.
AptarGroup CEO: Pharmaceutical consumer goods demand continues to be strong since Covid
AptarGroup CEO Stephan Tanda joins 'The Exchange' to discuss business trends in pharmaceutical retail products, areas of softness in consumer goods, and travel driving the beauty and skincare product ...
Aptar Reports Second Quarter 2023 Results
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Reports Second Quarter 2023 Results.
Aptar Announces Quarterly Dividend Increase of 7.9%
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Announces Quarterly Dividend Increase.
Aptar Reports First Quarter 2023 Results
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported stron...
Aptar Reports Fourth Quarter and Annual 2022 Results
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported net i...
Aptar Pharma Launches First Metal-Free Nasal Spray Pump, Meeting Growing Need for Highly Recyclable Packaging
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Pharma, part of AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery systems, services and active material science solutions, today announces the...
Aptar Declares Quarterly Dividend and Announces 2023 Annual Meeting Details
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today declared a ...
Aptar Announces 2023 Quarterly Conference Call Dates
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today announced t...
Aptar to Present at 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced their p...
Aptar in Top 15 of America's Most Responsible Companies 2023 by Newsweek
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, has been named on...
Aptar Announces the Realignment of Two of its Business Reporting Segments
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today announced t...
Aptar Again Named a Global Top Female-Friendly Company by Forbes
CRYSTAL LAKE, Ill.
Aptar and Chiesi Sign Digital Health Contract to bring Best-in-Class Disease Management Platform for Patients with Asthma and COPD
CRYSTAL LAKE, Ill.
Aptar Expands Pharmaceutical Services; Announces Exclusive Collaboration Between Aptar Pharma and Fluidda
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Expands Pharmaceutical Services and Announces Exclusive Collaboration Between Aptar Pharma and Fluidda.
Aptar Appoints Matthew L. Trerotola to its Board of Directors
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar announced today that Matt Trerotola has joined its Board of Directors.
Aptar Reports Second Quarter 2022 Results
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Reports Second Quarter 2022 Results